With regard to government expenditures on roadside testing devices for drug impairment, since January 1, 2017: (a) how many devices has the government provided to police departments, broken down by department; (b) what is the total amount spent on the devices; (c) how many devices does the government recommend each department have; (d) how many devices does each department currently have, according to latest information obtained by the government; and (e) what are the details of any specific funding which is currently in place to address the difference between how many devices each department currently has and how many devices each department is recommended to have?
Mr. Speaker, with regard to (a), currently, Public Safety, PS, has not provided any drug screening equipment to police departments. PS is working with all provinces and territories to determine their requirements and deployment plans for roadside testing devices in order to finalize funding levels and arrangements. The provinces are responsible for the administration of justice in their jurisdictions and determine their operational requirements. It is important to note that investigating drug-impaired driving is not dependent on roadside testing devices. They are an additional tool available to law enforcement. Many frontline law enforcement officers already have training to detect the signs and symptoms related to drug-impaired driving.
With regard to (b), the first drug screener was approved for use by the Attorney General of Canada on August 22, 2018. While notional funding allocations are being discussed with all provinces and territories, funding has not yet been finalized.
With regard to (c), the government does not make recommendations on operational policing matters. This is the responsibility of provinces and territories and law enforcement.
With regard to (d), information is not available.
With regard to (e), it is not applicable.
PS and the RCMP, in collaboration with the Canadian Council of Motor Transport Administrators, and law enforcement from across Canada, undertook a pilot project to test the use of oral fluid drug screening devices as tools to enhance the enforcement of drug-impaired driving. For the purposes of this project, drug screening devices and associated test kits were ordered for a total cost of $198,968.14.
For further information please visit the following website for information on the pilot project:
In addition, the RCMP purchased 20 drug screeners to provide initial training on the use of drug screeners to a cohort of trainers and frontline users in advance of October 17, 2018, for a total of $122,640.00.
Mr. Speaker, on August 30, 2018, the Federal Court of Appeal quashed the Trans Mountain expansion project’s federal certificate. The Government of Canada accepts the effect of the court’s decision and is committed to moving the project forward in the right way. In this regard, on September 20, 2018, the government directed the National Energy Board to reconsider its recommendation on the project in relation to environmental effects of project-related marine shipping.
On October 3, 2018, the government announced its intent to correct flaws noted by the court in the existing consultation with Indigenous peoples. Once those steps are complete, the government will consider all of the evidence, including new analysis by the National Energy Board and new information collected through indigenous consultation, and make a new decision on the project. It would be inappropriate for the government to prejudge the outcome of that decision until it can review all of the evidence.
When appropriate to do so, Trans Mountain Corporation will formally update the planned construction schedule and costs estimate for the expansion project. Accordingly, no estimate of the financial impact of the court’s decision is available at this time.